Improving heart health for pregnant women with high blood pressure in Nigeria
Improving Maternal Cardiovascular Outcomes Through the Implementation of a Hypertensive Disorders of Pregnancy Bundle in Nigeria
This study is testing a new program to help pregnant women in Nigeria with high blood pressure manage their condition better after giving birth.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 1200 (estimated) |
| Sex | Female |
| Sponsor | Washington University School of Medicine Academic / other |
| Locations | 4 sites (Abuja and 3 other locations) |
| Trial ID | NCT06859359 on ClinicalTrials.gov |
What this trial studies
This interventional study aims to develop and evaluate a Hypertensive Disorders of Pregnancy (HDP) Management package tailored for pregnant women in Nigeria. It focuses on implementing a postpartum remote blood pressure monitoring program, patient education, a standardized follow-up protocol, and providing subsidized antihypertensive medications. The study will assess the feasibility, fidelity, acceptability, and effectiveness of these interventions across four health institutions in Abuja and Kano. The primary goal is to determine if this contextualized approach leads to better blood pressure control among patients with HDP.
Who should consider this trial
Good fit: Ideal candidates include postpartum adults over 18 years old diagnosed with hypertensive disorders of pregnancy who delivered at one of the participating sites.
Not a fit: Patients who are unable to provide consent will not benefit from this study.
Why it matters
Potential benefit: If successful, this program could significantly improve cardiovascular health outcomes for postpartum women with hypertensive disorders in Nigeria.
How similar studies have performed: Other studies have shown success with similar approaches in managing hypertensive disorders during pregnancy, indicating potential for positive outcomes in this context.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Postpartum adults (\>18 years) * postpartum emancipated minors (in accordance with the Nigerian guidelines for young persons' participation in research and reproductive health services) * with diagnosis of HDP prior to delivery delivered at one of the participating sites able to provide informed consent. Exclusion Criteria: * unable to provide consent.
Where this trial is running
Abuja and 3 other locations
- National Hospital, Abuja — Abuja, Nigeria (Recruiting)
- University of Abuja Teaching Hospital — Abuja, Nigeria (Recruiting)
- Aminu Kano Teaching Hospital — Kano, Nigeria (Recruiting)
- Murtala Muhammad Specialist Hospital — Kano, Nigeria (Recruiting)
Study contacts
- Principal investigator: Zainab Mahmoud, MD, MSc — Washington University School of Medicine
- Study coordinator: Dike Ojji, MBBS, PhD
- Email: dike.ojji@uniabuja.edu.ng
- Phone: +234-806-009-4456
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.